BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25505722)

  • 1. IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blinded Pilot Study.
    Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Sanaka MR; Vargo JJ; Parsi MA
    Clin Endosc; 2014 Nov; 47(6):555-9. PubMed ID: 25505722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy.
    Vosskuhl K; Negm AA; Framke T; Weismüller T; Manns MP; Wedemeyer H; Plentz RR; Wedemeyer J; Lankisch TO
    Endoscopy; 2012 Jan; 44(1):48-52. PubMed ID: 22198775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.
    Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Liu X; Sanaka MR; Jang S; Vargo JJ; Parsi MA
    Dig Dis Sci; 2013 Oct; 58(10):2986-92. PubMed ID: 23828141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
    Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
    Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.
    Oseini AM; Chaiteerakij R; Shire AM; Ghazale A; Kaiya J; Moser CD; Aderca I; Mettler TA; Therneau TM; Zhang L; Takahashi N; Chari ST; Roberts LR
    Hepatology; 2011 Sep; 54(3):940-8. PubMed ID: 21674559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study.
    Navaneethan U; Gutierrez NG; Venkatesh PG; Jegadeesan R; Zhang R; Jang S; Sanaka MR; Vargo JJ; Parsi MA; Feldstein AE; Stevens T
    Am J Gastroenterol; 2014 Jun; 109(6):895-902. PubMed ID: 24710507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis: A retrospective cohort study of 39 IAC patients.
    Xiao J; Xu P; Li B; Hong T; Liu W; He X; Zheng C; Zhao Y
    Medicine (Baltimore); 2018 Feb; 97(8):e9767. PubMed ID: 29465558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4-associated cholangitis.
    Nath V; Lewin J; Subramony C; Shenoy V
    J Miss State Med Assoc; 2014 Dec; 55(12):384-8. PubMed ID: 25799760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.
    Boonstra K; Culver EL; de Buy Wenniger LM; van Heerde MJ; van Erpecum KJ; Poen AC; van Nieuwkerk KM; Spanier BW; Witteman BJ; Tuynman HA; van Geloven N; van Buuren H; Chapman RW; Barnes E; Beuers U; Ponsioen CY
    Hepatology; 2014 May; 59(5):1954-63. PubMed ID: 24375491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, Differential Diagnosis, and Epidemiology of Primary Sclerosing Cholangitis.
    Ponsioen CY
    Dig Dis; 2015; 33 Suppl 2():134-9. PubMed ID: 26640943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune cholangitis and cholangiocarcinoma.
    Li J; Zhao C; Shen Y
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1783-9. PubMed ID: 23034143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?
    Lytras D; Kalaitzakis E; Webster GJ; Imber CJ; Amin Z; Rodriguez-Justo M; Pereira SP; Olde Damink SW; Malagoʼ M
    Ann Surg; 2012 Dec; 256(6):1059-67. PubMed ID: 22580936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma.
    Kalaitzakis E; Levy M; Kamisawa T; Johnson GJ; Baron TH; Topazian MD; Takahashi N; Kanno A; Okazaki K; Egawa N; Uchida K; Sheikh K; Amin Z; Shimosegawa T; Sandanayake NS; Church NI; Chapman MH; Pereira SP; Chari S; Webster GJ
    Clin Gastroenterol Hepatol; 2011 Sep; 9(9):800-803.e2. PubMed ID: 21699807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing Biliary Strictures: Distinguishing IgG4-Related Sclerosing Cholangitis From Cholangiocarcinoma and Primary Sclerosing Cholangitis.
    Hori Y; Chari ST; Tsuji Y; Takahashi N; Inoue D; Hart PA; Uehara T; Horibe M; Yamamoto S; Satou A; Zhang L; Notohara K; Naitoh I; Nakazawa T
    Mayo Clin Proc Innov Qual Outcomes; 2021 Jun; 5(3):535-541. PubMed ID: 34195545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IgG4 associated autoimmune cholangitis].
    Färkkilä M
    Duodecim; 2011; 127(1):49-55. PubMed ID: 21442874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: a 30-Year Tertiary Care Experience.
    Roos E; Hubers LM; Coelen RJS; Doorenspleet ME; de Vries N; Verheij J; Beuers U; van Gulik TM
    Am J Gastroenterol; 2018 May; 113(5):765-772. PubMed ID: 29549357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center.
    Swensson J; Tirkes T; Tann M; Cui E; Sandrasegaran K
    Abdom Radiol (NY); 2019 Jun; 44(6):2111-2115. PubMed ID: 30783729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-Associated Cholangitis--A Mimic of PSC.
    Beuers U; Hubers LM; Doorenspleet M; Maillette de Buy Wenniger L; Klarenbeek PL; Boonstra K; Ponsioen C; Rauws E; de Vries N
    Dig Dis; 2015; 33 Suppl 2():176-80. PubMed ID: 26641633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma.
    Du S; Liu G; Cheng X; Li Y; Wang Q; Li J; Lu X; Zheng Y; Xu H; Chi T; Zhao H; Xu Y; Sang X; Zhong S; Mao Y
    J Clin Gastroenterol; 2016 Jul; 50(6):501-5. PubMed ID: 26974756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.